Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Hurley

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Ethics|December 20, 2014
How do we choose?Beverly M Small, Judith Hurley, Christine Placidi
Breast Cancer Research and Treatment|February 10, 2015
Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective studyAlexandra Gomez, Alberto J Montero, Judith Hurley
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2019
Endometrial cancer outcomes among non-Hispanic US born and Caribbean born black womenMatthew Schlumbrecht, Marilyn Huang, Judith Hurley, et al.
Cancer Investigation|May 25, 2002
Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanomaLynn G Feun, Niramol Savaraj, Judith Hurley, et al.
The Oncologist|November 11, 2018
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging IssueLuis E Aguirre, Maria E Guzman, Gilberto Lopes, et al.
Cancer Investigation|March 23, 2005
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanomaLynn Feun, Angela Marini, Frederick Moffat, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 31, 2013
Participation in cancer clinical trials: why are patients not participating?Margaret M Byrne, Stacey L Tannenbaum, Stefan Glück, et al.
Medicine|December 30, 2014
Locoregional outcomes in clinical stage IIB breast cancer after neoadjuvant therapy and mastectomy with or without radiationDayssy A Diaz, Judith Hurley, Isildinha Reis, et al.
Clinical Breast Cancer|December 9, 2004
Docetaxel and cisplatin as primary chemotherapy for treatment of locally advanced breast cancersYoung J Lee, Philomena Doliny, Carmen Gomez-Fernandez, et al.
Journal of Oncology|June 13, 2019
Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive PatientsDiana M Byrnes, Fernando Vargas, Christopher Dermarkarian, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Ethics|December 20, 2014
How do we choose?Beverly M Small, Judith Hurley, Christine Placidi
Breast Cancer Research and Treatment|February 10, 2015
Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective studyAlexandra Gomez, Alberto J Montero, Judith Hurley
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2019
Endometrial cancer outcomes among non-Hispanic US born and Caribbean born black womenMatthew Schlumbrecht, Marilyn Huang, Judith Hurley, et al.
Cancer Investigation|May 25, 2002
Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanomaLynn G Feun, Niramol Savaraj, Judith Hurley, et al.
The Oncologist|November 11, 2018
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging IssueLuis E Aguirre, Maria E Guzman, Gilberto Lopes, et al.
Cancer Investigation|March 23, 2005
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanomaLynn Feun, Angela Marini, Frederick Moffat, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 31, 2013
Participation in cancer clinical trials: why are patients not participating?Margaret M Byrne, Stacey L Tannenbaum, Stefan Glück, et al.
Medicine|December 30, 2014
Locoregional outcomes in clinical stage IIB breast cancer after neoadjuvant therapy and mastectomy with or without radiationDayssy A Diaz, Judith Hurley, Isildinha Reis, et al.
Clinical Breast Cancer|December 9, 2004
Docetaxel and cisplatin as primary chemotherapy for treatment of locally advanced breast cancersYoung J Lee, Philomena Doliny, Carmen Gomez-Fernandez, et al.
Journal of Oncology|June 13, 2019
Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive PatientsDiana M Byrnes, Fernando Vargas, Christopher Dermarkarian, et al.
Pageof 5